title: Impact of the administration of liposomal amphotericin B in patients with renal function impairment at initiation of treatment.
authors.affiliation: Servicio de Medicina Intensiva, Hospital Universitari del Mar, Autonomous University of Barcelona, Barcelona, Spain. Falvarez@imas.imim.es
authors.forename: F
authors.initials: F
authors.lastname: Alvarez-Lerma
authors.forename: F
authors.initials: F
authors.lastname: Mariscal
authors.forename: E
authors.initials: E
authors.lastname: Quintana
authors.forename: G
authors.initials: G
authors.lastname: Rialp
authors.forename: J
authors.initials: J
authors.lastname: Diaz-Reganon
authors.forename: M J
authors.initials: MJ
authors.lastname: Pérez San José
authors.forename: B
authors.initials: B
authors.lastname: Alvarez-Sanchez
mesh_terms: D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000097:blood; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy; D012189:Retrospective Studies
chemical_list: D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B; D003404:Creatinine